- Lobbying by ENDO PHARMACEUTICALS
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
|Kathryn Marks||Legislative Assistant, Senator John Edwards|
|Tim Trysla||Sr. Pol. Adv., CMS; Off. of Rep. Bill Archer Soc. Sec. Advisory Coun., Steelman Commission|
|Regina Sherick||Staff Assistant, Senate Finance Committee|
|Colin Roskey||Republican Staff, Senate Finance Committee|
|Kim Brandt||Technical Advisor to CFO, CMS Senior Counsel, Office of Inspector General Legislative Assistant, Rep. Paul Gillmor|
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate